Efficacy of resveratrol supplementation in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of clinical trials
S Rafiee, H Mohammadi, A Ghavami, E Sadeghi… - … therapies in clinical …, 2021 - Elsevier
Background Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver
disease and refers to the accumulation of triglycerides in hepatocytes. Recent studies have …
disease and refers to the accumulation of triglycerides in hepatocytes. Recent studies have …
Efficacy of resveratrol supplementation in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of clinical trials
S Rafiee, H Mohammadi, A Ghavami… - … therapies in clinical …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver
disease and refers to the accumulation of triglycerides in hepatocytes. Recent studies have …
disease and refers to the accumulation of triglycerides in hepatocytes. Recent studies have …
Efficacy of resveratrol supplementation in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of clinical trials.
S Rafiee, H Mohammadi, A Ghavami… - … Therapies in Clinical …, 2020 - europepmc.org
Background Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver
disease and refers to the accumulation of triglycerides in hepatocytes. Recent studies have …
disease and refers to the accumulation of triglycerides in hepatocytes. Recent studies have …